Lundberg B
Department of Biochemistry and Pharmacy, Abo Akademi University, Finland.
Anticancer Drug Des. 1994 Oct;9(5):471-6.
Low-density lipoprotein (LDL) is a potential drug carrier in cancer chemotherapy. Two novel cytotoxic lipophilic steroid derivatives with two nitrogen carbamate groups on a C-17 side chain were successfully incorporated into LDL using a reassembly technique. The antineoplastic activity of the new agents against T-47D breast cancer cells in culture was approximately twice that of a previously characterized compound with only one such group.
低密度脂蛋白(LDL)是癌症化疗中一种潜在的药物载体。利用重组技术,两种在C-17侧链上带有两个氮基甲酸酯基团的新型细胞毒性亲脂性类固醇衍生物成功地被整合到低密度脂蛋白中。在培养过程中,这些新药物对T-47D乳腺癌细胞的抗肿瘤活性约为先前表征的仅带有一个此类基团的化合物的两倍。